Akoustis Technologies Inc AKTS shares are trading lower by 30.6% to $0.49 during Thursday’s session after the company announced the pricing of its underwritten public offering of 20 million shares of common stock at $0.50 per share. The expected gross proceeds are approximately $10.0 million.
What Else?
The offering is managed by Roth Capital Partners, and Akoustis intends to use the net proceeds for various purposes, including operations, business growth, capital expenditures, research and development, technology commercialization, potential strategic transactions and general corporate purposes.
The underwriters have a 30-day option to purchase up to 3 million additional shares. The closing of the offering is anticipated around January 29, subject to market conditions.
See Also: US Q4 Economic Growth Hits 3.3%, Sharply Beats Estimates
According to data from Benzinga Pro, AKTS has a 52-week high of $4.96 and a 52-week low of $0.45.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.